Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway.
D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000201:enzymology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D012686:Septal Nuclei / Q000187:drug effects*; D013681:Tegmentum Mesencephali / Q000201:enzymology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D018377:Neurotransmitter Agents; D011759:Pyrrolidines; D005680:gamma-Aminobutyric Acid; D002262:Carboxy-Lyases; D005968:Glutamate Decarboxylase; D007608:Kainic Acid